Since its approval in 2011, transcatheter aortic valve replacement (TAVR) has been increasingly utilized as an effective alternative to surgical aortic valve replacement (SAVR). From 100% Medicare Fee-for-Service beneficiaries hospitalized… Click to show full abstract
Since its approval in 2011, transcatheter aortic valve replacement (TAVR) has been increasingly utilized as an effective alternative to surgical aortic valve replacement (SAVR). From 100% Medicare Fee-for-Service beneficiaries hospitalized between 2012 and 2017, we included patients with ICD-9 and
               
Click one of the above tabs to view related content.